|Bid||580.10 x 900|
|Ask||579.41 x 900|
|Day's range||576.83 - 583.44|
|52-week range||360.50 - 619.00|
|Beta (5Y monthly)||0.93|
|PE ratio (TTM)||50.04|
|Earnings date||21 Jul 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||556.43|
On this day, 244 years ago, all but one of the 13 United Colonies officially adopted the Declaration of Independence, thus declaring their collective right to govern without England calling the shots. If you have spare cash that won't be needed to pay bills or cover emergencies, then the following blend of growth and income stocks should be perfect to help you secure your financial freedom. The first top stock that'll put you on the path toward financial independence is e-commerce giant Amazon (NASDAQ: AMZN).
Overall, medical-device stocks are also beating the S&P 500 and healthcare stocks, in general, so far this year. Abbott Labs (NYSE: ABT) is second only to Johnson & Johnson on the list of the world's biggest medical-device stocks companies by market cap. There are two product lines that I think will be especially important growth drivers for Abbott in the second half of this year.
Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.
All an investor needs to do is to buy shares of public companies that have a competitive advantage -- and that, as a result, can continue generating growing revenue and earnings for decades -- and hold these shares for a long time. Today, we'll look at two healthcare stocks that sport a healthy moat, and explore why both of these stocks are worth adding to your portfolio. Vertex Pharma is a biotech company that has one of the most compelling competitive advantages any business can have: The company holds a monopoly in the market for drugs that treat the underlying causes of cystic fibrosis (CF), a genetic condition that causes damage to internal organs such as the lungs.
When you think "medical robots," what name jumps to mind first? When it comes to pure-play medical robotics companies that make robots to assist surgeons in performing their surgeries, Intuitive Surgical is the one to beat (rivals Mazor Robotics and Mako Surgical having already been gobbled up and subsumed into larger med-tech companies). As it turns out, when the Pentagon thinks about investing in surgical robots, Intuitive Surgical is the one they call, too.
While panic-selling can certainly be unnerving if you're a short-term trader, it's always been an opportunity to buy into great companies at a discount if you're a long-term investor. Throughout the 33-calendar-day decline in the broader market in February and March, I took the opportunity to add quite a few new companies to my investment portfolio. The single greatest thing about Intuitive Surgical is the fact that the company's operating margins are built to improve over time.
Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today provided an update on its efforts to support customers, communities, and its employees during the COVID-19 pandemic. Intuitive and the Intuitive Foundation are working to assemble, donate, and distribute personal protective equipment (PPE) to hospitals and healthcare facilities. The Intuitive Foundation is also connecting employees with opportunities to volunteer in their communities.
Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the election of Joseph C. Beery to its board of directors, effective April 23, 2020. “Joe has broad experience leading digital business capabilities, computing and information technology within global organizations, and we look forward to his insights and contributions as we expand our capabilities,” said Intuitive CEO Gary Guthart. Beery was senior vice president of Information Technology and Chief Information Officer for Thermo Fisher Scientific, a life sciences company, until his retirement in September 2019.
SUNNYVALE, Calif., April 16, 2020 -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted.
Investing.com - Intuitive Surgical on Thursday reported first-quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Intuitive (the “Company”) (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary first quarter 2020 operational results. Full financial results for the Company’s first quarter of 2020 will be provided on the Company’s earnings call scheduled for April 16, 2020. First quarter 2020 estimated worldwide da Vinci procedures increased approximately 10% compared with the first quarter of 2019.
To the annoyance of some shareholders, Intuitive Surgical (NASDAQ:ISRG) shares are down a considerable 33% in the last...
Let's talk about the popular Intuitive Surgical, Inc. (NASDAQ:ISRG). The company's shares saw a double-digit share...
Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced it has acquired privately held Orpheus Medical to deepen and expand its integrated informatics platform. Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in processing and archiving surgical video. “The addition of Orpheus will provide customers —including surgeons, patient care teams and hospitals—with ready access to and a deeper understanding of their data, which we believe may help our customers improve patient outcomes and lower total treatment costs,” said Julian Nikolchev, Intuitive’s senior vice president of corporate development and strategy.
Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Lonnie M. Smith has decided to retire from the company’s board of directors when his term ends at the company’s 2020 annual meeting of stockholders, currently scheduled for April. Mr. Smith will join the board of directors of the Intuitive Foundation after his retirement. Intuitive’s board of directors elected Dr. Craig H. Barratt to succeed Mr. Smith as chair effective as of the date of the company’s 2020 annual meeting of stockholders.
The acquisition is a step forward in Quest Diagnostics' (DGX) commitment toward offering high-quality, cost-efficient diagnostic services in Texas,especially the Houston metropolitan area.